Association of coffee consumption pattern and metabolic syndrome among middle-aged and older adults: A cross-sectional study

Objectives: The association between coffee consumption and the risk of metabolic syndrome (MetS) remains inconsistent. The aim of this study was to evaluate the association between coffee intake and components of MetS.

Method: A cross-sectional survey including 1,719 adults was conducted in Guangdong, China. Data on age, gender, education level, marriage status, body mass index (BMI), current smoking and drinking status and breakfast habit, coffee consumption type, and daily servings were derived based on 2-day, 24-h recall. MetS were assessed according to the International Diabetes Federation definition. Multivariable logistic regression was conducted to examine the association between the coffee consumption type, daily servings, and the components of MetS.

Results: Regardless of the coffee type, compared with non-coffee consumers, coffee consumers had higher odds ratios (ORs) of the elevated fasting blood glucose (FBG) in both men [OR: 3.590; 95% confidence intervals (CI): 2.891–4.457] and women (OR: 3.590; 95% CI: 2.891–4.457). In women, the risk of elevated blood pressure (BP) was 0.553 times (OR: 0.553; 95% CI: 0.372–0.821, P = 0.004) for people who drank total coffee > 1 serving/day than for non-coffee drinkers.

Conclusion: In conclusion, regardless of type, coffee intake is associated with an increased prevalence of FBG in both men and women, but has a protective effect on hypertension only in women.

Introduction

Metabolic syndrome (MetS), defined as the presence of physiologically related cardiovascular risk factors, including dyslipidemia, abdominal obesity, hyperglycemia, and hypertension, is closely correlated with increased cardiovascular risk and common cancers (1–3). The prevalence of MetS has considerably increased over recent decades and is now at epidemic proportions worldwide (4, 5). Insulin resistance is a key hallmark feature of MetS and a critical risk factor for diabetes and other cardiovascular diseases (CVD) (6). Recently, accumulating epidemiological and experimental evidence point out that MetS is affected by genetic (7–9) and lifestyle factors (10, 11), including smoking, alcohol consumption, sugar-sweetened beverage consumption physical activity, and sedentary behaviors. Indeed, MetS have been inversely affected by dietary intakes, such as vegetables, fruits, red wine, and green tea (12). Therefore, experts emphasize dietary intakes for the primary interventions on MetS prevention (13, 14).

Coffee, which has antioxidant properties and a distinctive smell and taste, is now one of the world's most popular beverages (15). With the far-reaching development of industry and rapid changes in dietary lifestyles, coffee consumption has been considerably increasing in Shenzhen. The constituents in coffee, including polyphenols, antioxidant properties, caffeine, potassium, niacin, vitamin E, and magnesium, have been proposed to be beneficial for potential health. Experimental studies revealed that caffeine might protect against type 2 diabetes mellitus (T2DM) by stimulating free fatty acid and fat oxidation release from peripheral tissues, increasing metabolic rate and thermogenesis, and mobilizing glycogen in muscles (16). Therefore, epidemiologic studies reported a significant association between higher coffee consumption and decreased incidence of new-onset hypertension (17, 18), arterial stiffness (19, 20), T2DM (21), and promote weight loss (22). However, another study conducted in the Japanese setting demonstrated that certain types of coffee led to an increase in all-cause mortality (23). Also, other investigations reported that the intake of coffee with creamer or sugar was significantly associated with increased abdominal obesity (24) and risk of MetS (25).

The above inconsistent findings might be caused by different research designs, that is, some focused on the effect of daily coffee consumption volume, while others focused on the habitual coffee pattern. However, daily consumption patterns of coffee containing both quantitative and qualitative information are still lacking. For this reason, we performed a cross-sectional study to examine the association between coffee consumption patterns and MetS components among middle-aged and older adults.

Materials and methods

Study population

This cross-sectional survey was based on a large-scale, community-based routine health examination for the middle-aged and elderly. In total, 2,200 participants aged 40 years and above were recruited from January 2021 to March 2022 in Guangdong province. All individuals received a routine health check-up, including venous blood sampling and anthropometry. Among these, a subset of the individuals (n = 2,066) completed the 24-h food recall. Furthermore, we excluded individuals with a history of ischemic heart disease (n = 12) or stroke (n = 21), and those who take drugs to treat hyperlipidemia, diabetes, or hypertension (n = 314). Finally, 1,719 participants (800 men and 919 women) were included in the present study. The study was approved by the Ethics Committee of the Health Science Centre, Shenzhen University. All individuals signed written informed consent before participation.

Diagnosis of mets

According to the guidance of the updated National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) (26), individuals who met at least three of the following criteria were diagnosed with MetS: (1) waist circumference (WC) ≥ 90 cm in men, ≥ 80 cm in women; (2) systolic blood pressure (SBP) ≥ 130 mmHg or diastolic blood pressure (DBP) ≥ 85 mmHg; (3) fasting blood glucose (FBG) ≥ 5.60 mmol/L; (4) blood high-density lipoprotein cholesterol (HDL-C) level < 40 mg/dL in men, < 50 mg/dL in women; (5) blood triglyceride (TG) ≥ 1.70 mmol/L.

Anthropometric and biochemical measurement

At the mobile physical examination centers, anthropometric variables including weight, height, and blood pressure (BP) were measured using standardized calibrated equipment under the guidance of professional medical staff. Body mass index (BMI, kg/m²) was calculated as weight divided by the height squared. WC was measured at the narrowest between the iliac crest and the bottom of the ribs. BP was measured by a sphygmomanometer (Yu yue, YJ100002, Jiangsu, China) on the right arm after the individual had been supine for at least 20 min, and the mean value of three times record was used. Biochemical assessment variables including FBG, HDL-C, TG, and 2 h post-load glucose (2hPG) were assessed using a semi-automated analyzer (Sysmex 100 XN-3000, Tokyo, Japan) enzymatically after fasting for at least 8 h. Furthermore, a detailed data collection process was reported elsewhere (27).

Coffee consumption measurement

Information regarding coffee consumption was obtained based on a 2-day, 24-h recall. Individuals who drank coffee at least three times per week were described as coffee drinkers (28). The habitual coffee consumption questionnaire included habitual coffee type and daily coffee serving frequency. Black coffee was described as coffee powder or extracts without other ingredients. Coffee with creamer, milk, or sugar was defined as instant coffee. Other coffee is a collective name, covering a series of other types of coffee, excluding black coffee, and instant coffee. Based on the type of coffee they consumed, individuals were classified into the following five categories: non-coffee consumers, black coffee consumers, instant coffee consumers, other coffee consumers, and coffee consumers. If only black coffee or instant coffee was in a person's 2-day, 24-h food recall, the individual was determined as a black coffee or instant coffee consumer, respectively. Meanwhile, individuals who consumed any coffee type that appeared at least once were classified as coffee consumers. Other coffee consumers referred to participants who consumed other type's coffee.

Demographic measurement

Demographic information of participants including age, gender, education level, marital status, current smoking and drinking status, breakfast habits, physical activity, and sitting time was collected through questionnaires. The level of education was categorized as up to junior high school, high school or secondary specialized school, and college and above. Marital status categories included unmarried, married or cohabiting, and others (divorced, separated, or widowed). Current smoking and drinking status were categorized as yes or no. Breakfast categories included none, 1–3 times/week, 4–5 times/week, and every day. Physical activity divided into four categories: < 0.5, 0.5–1, 1–2, and > 2 h/day. Sitting time divided into four categories: < 6, 6–8, 8–10, and > 10 h/day.

Statistical analysis

All data are presented as mean (standard deviation) for continuous data and as percentages for categorical data according to the Shapiro–Wilk test of normality. Participants' demographic characteristics including age, education level, marital status, BMI, body weight status, current smoking and drinking status, breakfast habit, physical activity, sitting time, and Mets parameters according to coffee consumption type by gender, were compared using the Chi-square test for categorical variables and generalized linear model for continuous variables. A multivariate-adjust logistic regression model was conducted to explore the association between coffee consumption patterns and MetS components. We assigned the median of daily servings of coffee as a continuous variable and performed stratified analysis across coffee consumption categories. We adjusted covariates including BMI, education level, alcohol status, and physical activity for all the regression models, and the 95% confidence intervals (CIs) of odds ratios (ORs) were estimated. A two-sided P-value of < 0.05 was considered statistical significance, and SAS software (version 9.4) was used to conduct all analyses.

Results

Table 1 presented the participants' demographic characteristics according to coffee consumption categories by gender. In men, the proportion of participants in high school or secondary specialized school was the largest for all coffee consumption categories (P < 0.05). In men, mean BMI and FBG levels were significantly higher in instant coffee consumers than in other groups (all P < 0.05). In women, mean BMI, SBP, and FBG levels were significantly higher in other coffee consumers than in other groups (all P < 0.05). In both men and women, the proportion of participants with normal weight status was the largest for all coffee consumption categories (all P < 0.05). In men, non-alcohol drinkers were more likely to be non-coffee consumers, while compared with non-alcohol drinkers, the proportion of alcohol consumers was higher than nondrinkers in the other three types of coffee pattern groups (all P < 0.05). In men, the duration of physical activity was higher in black coffee consumers than in the other three types of coffee pattern groups (P < 0.05).

TABLE 1

Table 1. General characteristics of the cross-sectional study population according to coffee consumption pattern by gender.

Table 2 summarized the multivariable-adjusted OR and 95% CI of MetS components across the type of coffee by gender. Regardless of the coffee type, compared with non-coffee consumers, coffee consumers had higher ORs of the elevated FBG in both men (OR: 3.590; 95% CI: 2.891–4.457) and women (OR: 3.590; 95% CI: 2.891–4.457). In women, the prevalence of elevated blood pressure (OR: 0.661; 95% CI: 0.454–0.963) was significantly lower in black coffee consumers than in non-coffee consumers. The same inverse association can be also found in other types of coffee consumption.

TABLE 2

Table 2. Multivariable-adjusted odds ratios and 95% CIs for metabolic components according to the type of coffee consumed (by gender).

We further conducted stratified analyses to explore multivariable-adjusted OR and 95% CI for MetS according to daily servings of coffee by gender, as presented in Table 3. In male black coffee drinkers, there was a linear trend between the increase of TG and the decrease in coffee consumption (P < 0.05). In addition, men who drank coffee > 1 serving/day had an increased risk of elevated FBG (OR: 4.112; 95% CI: 2.537–6.666; P < 0.05). The same results were also observed in men who drank black coffee (OR: 3.835; 95% CI: 2.009–7.319; P < 0.001) and instant coffee (OR: 3.651; 95% CI: 1.329–10.031; P < 0.001). In women, there was a positive correlation between coffee consumption and elevated FBG. The risk of elevated FBG in people who drink > 1 serving/day is 3.798 times higher than that in people who drink ≤ 1 serving/day (OR: 3.798; 95% CI: 2.555–5.647, P < 0.001), and the same results can be found in women who drink black coffee and instant coffee. The risk of elevated FBG was 3.109 times (OR: 3.109; 95% CI: 1.799–5.371, P < 0.001) in women who drank black coffee and 3.514 times (OR: 3.109; 95% CI: 1.503–8.218, P < 0.001) in women who drank instant coffee. In women, compared with non-coffee consumers, there was a negative correlation between coffee consumption and elevated BP. The risk of elevated BP was 0.553 times (OR: 0.553; 95% CI: 0.372–0.821, P = 0.004) for people who drank coffee > 1 serving/day than for non-coffee drinkers in total coffee. The risk of elevated BP was 0.516 times that of non-coffee drinkers (OR: 0.516; 95% CI: 0.296–0.898, P = 0.005) in black coffee. Among instant coffee drinkers, the risk of elevated BP was 0.276 times that of non-coffee drinkers (OR: 0.276; 95% CI: 0.112–0.68, P = 0.037).

TABLE 3

Table 3. Multivariable-adjusted odds ratios and 95% CIs for metabolic components according to daily servings of coffee (by gender).

Discussion

The current study examined the associations between coffee consumption patterns and MetS components among middle-aged and older adults in Guangdong. We found that both black coffee and instant coffee had positive associations with elevated FBG. Furthermore, these positive associations were robust in the stratified analyses among participants who consumed ≤ 1 vs. >1 Serving daily. In addition, according to gender-stratified analysis, regardless of the coffee type, women who drank a good amount of coffee were significantly associated with a lower prevalence of elevated BP than non-coffee consumers. Whereas, the same results could not be found in men. Our results revealed that habitual coffee drinking could prevent women from hypertension in a certain sense.

Our study suggested that most of the participants were of normal weight regardless of the coffee consumption type. But, in both men and women, compared with non-coffee consumers, coffee consumers were more likely to have a higher BMI. These findings are not in line with previous epidemiology studies. In a national wide cross-sectional study conducted in 2003–2004, coffee consumption was not significantly associated with BMI or waist circumference in either men or women (29). However, another cross-sectional study in Poland revealed that lower coffee consumption was significantly associated with a higher risk of obesity (30). The inconsistency may be caused by the differences in diet assessment measures and study population. The previous survey collected the data by the means of a validated food frequency questionnaire (FFQ) to measure coffee consumption, which may cause non-differential misclassification, leading to biased study results (31). Furthermore, the response categories of FFQ were close-ended, which may lead to an underestimation of coffee consumption (32). In the current survey, we adapted a 2-day, 24-h food recall to assess participants' habitual coffee consumption, which could avoid the mentioned above biases.

Unexpectedly, we found that compared to non-coffee consumers, participants who consumed ≤ 1 serving/day or >1 serving/day of any coffee were more likely to have increased FBG levels in both men and women. The results are not consistent with findings from previous epidemiologic surveys. In a cross-sectional prospective study in Dutch, higher coffee consumption tended to be significantly associated with a lower risk of T2DM (33). While numerous prospective cohort studies indicated the inverse relationship between habitual coffee consumption and the incidence of T2DM (34). This inconsistency could be attributed to various factors, such as coffee consumption type, dose, and other constitutional and environmental factors.

The mechanism of the association between coffee consumption and plasma glucose remains unclear yet. Caffeine, one of the main bioactive compounds in coffee, has numerous biological impacts on all aspects of human health (35). A previous experimental study indicated that short-term coffee consumption could impair glucose tolerance and reduce insulin sensitivity due to the A1 attenuating aortic dissection affected by the caffeine-blocking; however, this effect will not last long (36). Long-term coffee consumption could prevent the incidence of T2DM by affecting post-load rather than fasting glucose metabolism (37). On the other hand, the effect of caffeine on plasma glucose is determined by the glycemic index of food (38). From a genetic point of view, Robertson et al. revealed that the plasma glucose level might be affected by the plasma glucose level, such as rs762551 single-nucleotide polymorphism in the CYP1A2 gene, which can directly affect the rate of the body's metabolism of caffeine (39). In this aspect, CYP1A2 activity can be effected by numerous environmental factors, including race, gender, smoking, and drinking status. Another experimental study suggested that compared to baseline, fasting glucose concentrations were higher after consuming 1 L of coffee daily for 2 weeks, but not after 4 weeks, indicating that caffeine is substantially influenced by the development of tolerance (40). Therefore, the inconsistent results in the current study may be attributed to the ignorance of caffeine dose, and the participants were old, so as to affect the metabolism of caffeine.

In the current study, we found that the protective effect of habitual coffee drinking on BP was significant only in women. In line with this finding, Grosso et al. (41) reported that higher coffee consumption was associated with a decreased risk of hypertension appeared to be significant only in women (41). Actually, numerous epidemiological studies on the influence of coffee or caffeine on the incidence of CVD system have provided controversial and inconsistent findings. A systematic review and meta-analysis of randomized controlled clinical trials indicated that habitual coffee consumption can slightly increases SBP and DBP (42). In this regard, some previous studies reported a negative association between habitual coffee consumption and the risk of CVD (43, 44), while others revealed a positive association (45), or no significant association (46). Another recent meta-analysis revealed that BP elevations tended to be associated only with caffeine but not coffee (47). Thus, these conflicting findings may be due to the different types of brewing coffee, various confounding dietary factors, and the daily consuming amount.

Overall, the caffeine acute effects on BP are well-known, but the mechanism underlying the effect of chronic coffee consumption remains unclear (48). There is experimental evidence that an acute raise in BP due to coffee intake develops increasing tolerance, and intravenous caffeine led to a rise in muscle sympathetic activity and increased BP among both non-habitual and habitual coffee consumers, while coffee dietary consumption led to elevated BP on existed in non-habitual coffee consumers (49). This may be the reason that, compared to non-coffee consumers, habitual coffee consumers are less likely to show an average BP response after coffee intake. Moreover, phenolic, the main compound of coffee, can play a key role in regulating the cellular processes that lead to inflammatory responses (50). Oxidative stress has a great impact on the process that causes metabolism impairment and chronic conditions development, including hypertension (51). In this aspect, women have more antioxidants than men in natural differences (52), this may explain the gender difference in coffee consumption effect. From the point of view of genetics, lifestyle habits (such as drinking or smoking status) or genetics may influence the activity of enzymes so as to affect metabolize caffeine and BP levels. Taking into account all variables mentioned earlier, it may explain the significant protective effect of coffee intake for women but not men.

To the best of our knowledge, the current study is the first to discuss the association between coffee consumption patterns and MetS among middle-aged and older adults in Shenzhen. We assessed individuals' coffee consumption patterns upon 2-day, 24-h recall data, which can relatively obtain accurate information about habitual coffee consumption. Moreover, we estimated both coffee consumption type and daily serving times of each type, so as to provide not only qualitative but also quantitative information regarding coffee consumption patterns. However, several limitations should be noted. First, the causal associations between coffee consumption patterns and MetS could not be confirmed due to the cross-sectional nature. Second, we did not include actual consumption volumes, brewing method, sugar in coffee or other coffee ingredient consumption, total energy intake, and presence of caffeine were not obtained. Third, the study only included healthy residents, it may be potential for residual confounding factors and other lifestyle factors. Multilateral studies considering coffee consumption timing, volumes, frequency, ingredients, and other behavioral factors by gender are needed to address the association of coffee consumption patterns on MetS in a more expanded population.

Conclusion

In conclusion, a significant positive association between coffee consumption patterns and elevated FBG in both men and women was found, whereas consumption was inversely associated with elevated BP only in women. Our findings reinforce the hypothesis on the possible benefits of hypertension for women. Due to methodological limitations, further research prospective studies or well-designed randomized controlled trials are needed to confirm the causal association.

Data availability statement

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.

Ethics statement

The studies involving human participants were reviewed and approved by the Ethics Committee of the Health Science Centre, Shenzhen University. The patients/participants provided their written informed consent to participate in this study.

Author contributions

RN and ZY conceived the study. RN, HL, LQ, GH, SL, and ZY collected data. RN and GH provided the recruitment resources. RN completed the original draft preparation. ZY reviewed, edited the final draft, and received the funding. All authors contributed to the article and approved the submitted version.

Funding

This research was funded by the General Program of Stable Support Plan for Universities in Shenzhen City (grant no. 20200812135338001) and the SZU Top Ranking Project (grant no. 86000000210).

Acknowledgments

We sincerely thank all the participants of the study.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Reynolds K, He J. Epidemiology of the metabolic syndrome. Am J Med Sci. (2005) 330:273–79. doi: 10.1097/00000441-200512000-00004

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. (2005) 365:1415–28. doi: 10.1016/S0140-6736(05)66378-7

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Huang J, Huang J, Wang J, Chung V, Wong M. Metabolic syndrome and risk of cancer in Chinese populations: a systematic review and meta-analysis in 57 260 individuals. Lancet. (2018) 392:S15. doi: 10.1016/S0140-6736(18)32644-8

CrossRef Full Text | Google Scholar

4. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults - findings from the third national health and nutrition examination survey. J Am Med Assoc. (2002) 287:356–59. doi: 10.1001/jama.287.3.356

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among US Adults: NHANES III to NHANES 1999-2006. Diabetes Care. (2011) 34:216–19. doi: 10.2337/dc10-0879

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Lu M, Cheng H, Lai JC, Chen S. The relationship between habitual coffee drinking and the prevalence of metabolic syndrome in Taiwanese adults: evidence from the Taiwan biobank database. Nutrients. (2022) 14:1867. doi: 10.3390/nu14091867

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Song Y, Sung J, Lee K. Genetic and environmental relationships of metabolic and weight phenotypes to metabolic syndrome and diabetes: the healthy twin study. Metab Syndr Relat D. (2015) 13:36–44. doi: 10.1089/met.2014.0087

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Brown AE, Walker M. Genetics of insulin resistance and the metabolic syndrome. Curr Cardiol Rep. (2016) 18:1–8. doi: 10.1007/s11886-016-0755-4

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Gao M, Ding D, Huang J, Qu Y, Wang Y, Huang Q. Association of genetic variants in the adiponectin gene with metabolic syndrome: a case-control study and a systematic meta-analysis in the Chinese population. Plos ONE. (2013) 8:58412. doi: 10.1371/journal.pone.0058412

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Kim U, Choi E, Park H, Lee H, Park B, Kim H, Hong Y, Jung S, Park H. The mediating effect of inflammation between the dietary and health-related behaviors and metabolic syndrome in adolescence. Nutrients. (2022) 14:2339. doi: 10.3390/nu14112339

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Da Silva Moura AR, Rebelo Sampaio Da Paz SM, Goncalves Frota KDM, Resende Goncalves De Carvalho CM. Lifestyle associated with risk for metabolic syndrome in adults and the elderly. Nutrition. (2022) 99:111647. doi: 10.1016/j.nut.2022.111647

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Grosso G, Pajak A, Mistretta A, Marventano S, Raciti T, Buscemi S, et al. Protective role of the Mediterranean diet on several cardiovascular risk factors: Evidence from Sicily, southern Italy. Nutr Metab Cardiovas. (2014) 24:370–77. doi: 10.1016/j.numecd.2013.09.020

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Julibert A, Del Mar Bibiloni M, Mateos D, Angullo E, Tur JA. Dietary fat intake and metabolic syndrome in older adults. Nutrients. (2019) 11:1901. doi: 10.3390/nu11081901

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Mazidi M, Pennathur S, Afshinnia F. Link of dietary patterns with metabolic syndrome: analysis of the national health and nutrition examination survey. Nutr Diabetes. (2017) 7:11. doi: 10.1038/nutd.2017.11

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Samoggia A, Riedel B. Consumers perceptions of coffee health benefits and motives for coffee consumption and purchasing. Nutrients. (2019) 11:653. doi: 10.3390/nu11030653

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Jiang X, Zhang D, Jiang W. Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies. Eur J Nutr. (2014) 53:25–38. doi: 10.1007/s00394-013-0603-x

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Grosso G, Micek A, Godos J, Pajak A, Sciacca S, Bes-Rastrollo M, Galvano F, Martinez-Gonzalez MA. Long-term coffee consumption is associated with decreased incidence of new-onset hypertension: a dose-response meta-analysis. Nutrients. (2017) 9:890. doi: 10.3390/nu9080890

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Saeed M, Naveed M, BiBi J, Ali Kamboh A, Phil L, Chao S. Potential nutraceutical and food additive properties and risks of coffee: a comprehensive overview. Crit Rev Food Sci. (2019) 59:3293–319. doi: 10.1080/10408398.2018.1489368

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Suzuki A, Nomura T, Jokura H, Kitamura N, Saiki A, Fujii A. Chlorogenic acid-enriched green coffee bean extract affects arterial stiffness assessed by the cardio-ankle vascular index in healthy men: a pilot study. Int J Food Sci Nutr. (2019) 70:901–08. doi: 10.1080/09637486.2019.1585763

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Echeverri D, Pizano A, Montes FR, Forcada P. Acute effect of coffee consumption on arterial stiffness, evaluated using an oscillometric method. Artery Res. (2017) 17:16–32. doi: 10.1016/j.artres.2017.01.001

CrossRef Full Text | Google Scholar

21. Mattias C, Larsson SC. Coffee consumption and reduced risk of developing type 2 diabetes: a systematic review with meta-analysis. Nutr Rev. (2018) 76:395–417. doi: 10.1093/nutrit/nuy014

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Moran-Lev H, Cohen S, Zelber-Sagi S, Mazkeret Mayer E, Anafy A, Yerushalmy-Feler A, et al. Effect of coffee and tea consumption on adolescent weight control: an interventional pilot study. Child Obes. (2022). doi: 10.1089/chi.2022.0032

PubMed Abstract | CrossRef Full Text | Google Scholar

23. Abe SK, Saito E, Sawada N, Tsugane S, Ito H, Lin Y, et al. Coffee consumption and mortality in Japanese men and women: a pooled analysis of eight population-based cohort studies in Japan (Japan cohort consortium). Prev Med. (2019) 123:270–77. doi: 10.1016/j.ypmed.2019.04.002

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Lee J, Kim HY, Kim J. Coffee consumption and the risk of obesity in Korean women. Nutrients. (2017) 9:1340. doi: 10.20944/preprints201709.0165.v1

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Shang F, Li X, Jiang X. Coffee consumption and risk of the metabolic syndrome: a meta-analysis. Diabetes Metab. (2016) 42:80–7. doi: 10.1016/j.diabet.2015.09.001

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome - an american heart association/national heart, lung, and blood institute scientific statement. Curr Opin Cardiol. (2006) 21:1–06. doi: 10.1097/01.hco.0000200416.65370.a0

PubMed Abstract | CrossRef Full Text | Google Scholar

27. Zhang Y, Xie Y, Huang L, Zhang Y, Li X, Fang Q, et al. Association of sleep duration and self-reported insomnia symptoms with metabolic syndrome components among middle-aged and older adults. Int J Environ Res Public Health. (2022) 18:11637. doi: 10.3390/ijerph191811637

PubMed Abstract | CrossRef Full Text | Google Scholar

28. Shih Y, Wu H, Pan W, Chang H. Increased coffee, tea, or other sugar-sweetened beverage consumption in adolescents is associated with less satisfactory dietary quality, body fatness and serum uric acid profiles over the past 18 years in Taiwan. Asia Pac J Clin Nutr. (2019) 28:371–82. doi: 10.6133/apjcn.201906_28(2).0020

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Bouchard DR, Ross R, Janssen I. Coffee, tea and their additives: association with bmi and waist circumference. Obes Facts. (2010) 3:345–52. doi: 10.1159/000322915

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Suliga E, Koziel D, Ciesla E, Rebak D, Gluszek S. Coffee consumption and the occurrence and intensity of metabolic syndrome: a cross-sectional study. Int J Food Sci Nutr. (2017) 68:507–13. doi: 10.1080/09637486.2016.1256381

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Olga P, Athanasia S, Nikolaos R, Charalampia D, Antonios K. Development and validation of a functional foods frequency questionnaire for Greek adults. Curr Top Nutraceut R. (2021) 19:373–81. doi: 10.37290/ctnr2641-452X.19:373-381

CrossRef Full Text | Google Scholar

32. Watson EJ, Kohler M, Banks S, Coates AM. Validation and reproducibility of an Australian caffeine food frequency questionnaire. Int J Food Sci Nutr. (2017) 68:617–26. doi: 10.1080/09637486.2016.1268102

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Van Dam RM, Dekker JM, Nijpels G, Stehouwer C, Bouter LM, Heine RJ. Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study. Diabetologia. (2004) 47:2152–59. doi: 10.1007/s00125-004-1573-6

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Ding M, Bhupathiraju SN, Chen M, Van Dam RM, Hu FB. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis. Diabetes Care. (2014) 37:569–86. doi: 10.2337/dc13-1203

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Ricci E, Vigano P, Cipriani S, Somigliana E, Chiaffarino F, Bulfoni A, Parazzini F. Coffee and caffeine intake and male infertility: a systematic review. Nutr J. (2017) 16:1–14. doi: 10.1186/s12937-017-0257-2

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Zhang Z, Jiang Y, Zhou Z, Huang J, Chen S, Zhou W, et al. Scavenger receptor A1 attenuates aortic dissection via promoting efferocytosis in macrophages. Biochem Pharmacol. (2019) 168:392–403. doi: 10.1016/j.bcp.2019.07.027

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Mirmiran R, Carlstrom M, Bahadoran Z, Azizi F. Long-term effects of coffee and caffeine intake on the risk of pre-diabetes and type 2 diabetes: Findings from a population with low coffee consumption. Nutr Metab Cardiovas. (2018) 28:1261–66. doi: 10.1016/j.numecd.2018.09.001

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Moisey LL, Kacker S, Bickerton AC, Robinson LE, Graham TE. Caffeinated coffee consumption impairs blood glucose homeostasis in response to high and low glycemic index meals in healthy men. Am J Clin Nutr. (2008) 87:1254–61. doi: 10.1093/ajcn/87.5.1254

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Robertson TM, Clifford MN, Penson S, Williams P, Robertson MD. Postprandial glycaemic and lipaemic responses to chronic coffee consumption may be modulated by CYP1A2 polymorphisms. Brit J Nutr. (2018) 119:792–800. doi: 10.1017/S0007114518000260

PubMed Abstract | CrossRef Full Text | Google Scholar

40. Van Dam RM, Pasman WJ, Verhoef P. Effects of coffee consumption on fasting blood glucose and insulin concentrations – Randomized controlled trials in healthy volunteers. Diabetes Care. (2004) 27:2990–92. doi: 10.2337/diacare.27.12.2990

PubMed Abstract | CrossRef Full Text | Google Scholar

41. Grosso G, Stepaniak U, Polak M, Micek A, Topor-Madry R, Stefler D, et al. Coffee consumption and risk of hypertension in the Polish arm of the HAPIEE cohort study. Eur J Clin Nutr. (2016) 70:109–15. doi: 10.1038/ejcn.2015.119

PubMed Abstract | CrossRef Full Text | Google Scholar

42. Noordzij M, Uiterwaal C, Arends LR, Kok FJ, Grobbee DE, Geleijnse JM. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens. (2005) 23:921–28. doi: 10.1097/01.hjh.0000166828.94699.1d

PubMed Abstract | CrossRef Full Text | Google Scholar

43. Schaefer SM, Kaiser A, Behrendt I, Eichner G, Fasshauer M. Association of alcohol types, coffee and tea intake with mortality: prospective cohort study of UK Biobank participants. Brit J Nutr. (2022). doi: 10.3390/brainsci12030360

PubMed Abstract | CrossRef Full Text | Google Scholar

44. Ding M, Satija A, Bhupathiraju SN, Hu Y, Sun Q, Han J, Lopez-Garcia E, Willett W, van Dam RM, Hu FB. Association of coffee consumption with total and cause-specific mortality in 3 large prospective cohorts. Circulation. (2015) 132:2305. doi: 10.1161/CIRCULATIONAHA.115.017341

PubMed Abstract | CrossRef Full Text | Google Scholar

45. Grioni S, Agnoli C, Sieri S, Pala V, Ricceri F, Masala G, et al. Espresso coffee consumption and risk of coronary heart disease in a large Italian cohort. Plos ONE. (2015) 10: 126550. doi: 10.1371/journal.pone.0126550

PubMed Abstract | CrossRef Full Text | Google Scholar

46. Floegel A, Pischon T, Bergmann MM, Teucher B, Kaaks R, Boeing H. Coffee consumption and risk of chronic disease in the European prospective investigation into cancer and nutrition (EPIC)-germany study. Am J Clin Nutr. (2012) 95:901–08. doi: 10.3945/ajcn.111.023648

PubMed Abstract | CrossRef Full Text | Google Scholar

47. Eumann Mesas A, Leon-Munoz LM, Rodriguez-Artalejo F, Lopez-Garcia E. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: a systematic review and meta-analysis. Am J Clin Nutr. (2011) 94:1113–26. doi: 10.3945/ajcn.111.016667

PubMed Abstract | CrossRef Full Text | Google Scholar

48. Miranda AM, Steluti J, Fisberg RM, Marchioni DM. Association between coffee consumption and its polyphenols with cardiovascular risk factors: a population-based Study. Nutrients. (2017) 9:276. doi: 10.3390/nu9030276

PubMed Abstract | CrossRef Full Text | Google Scholar

49. Maserejian NN, Wager CG, Giovannucci EL, Curto TM, McVary KT, McKinlay JB. Intake of caffeinated, carbonated, or citrus beverage types and development of lower urinary tract symptoms in men and women. Am J Epidemiol. (2013) 177:1399–410. doi: 10.1093/aje/kws411

PubMed Abstract | CrossRef Full Text | Google Scholar

50. Okur I, Soyler B, Sezer P, Oztop MH, Alpas H. Improving the recovery of phenolic compounds from spent coffee grounds (SCG) by environmentally friendly extraction techniques. Molecules. (2021) 26:613. doi: 10.3390/molecules26030613

PubMed Abstract | CrossRef Full Text | Google Scholar

51. Griendling KK, Camargo LL, Rios FJ, Alves-Lopes R, Touyz RM. Oxidative stress and hypertension. Circ Res. (2021) 128:993–1020. doi: 10.1161/CIRCRESAHA.121.318063

PubMed Abstract | CrossRef Full Text | Google Scholar

52. Viña J, Borrás C. Women live longer than men: understanding molecular mechanisms offers opportunities to intervene by using estrogenic compounds. Antioxid Redox Sign. (2010) 13:269–78. doi: 10.1089/ars.2009.2952

PubMed Abstract | CrossRef Full Text | Google Scholar